This session will provide an update on what every PA needs to know about HIV in 2025. While HIV medicine has evolved significantly during the past four decades, over 35,000 HIV infections occur annually in the U.S. The epidemiology continues to change with infections disproportionately affecting residents of southern states, people of color, and sexual and gender minorities. Clinical guidelines incorporate screening for HIV into routine medical care. Prevention continues to expand with increased utilization of antiretroviral-mediated prevention including preexposure prophylaxis and treatment as prevention, with new long-acting injectable medication options. Long-term survivors face new complications including certain cancers and inflammatory-mediated disease. While HIV can be considered a chronic disease, the societal stigma surrounding this disease requires that providers approach HIV with a unique perspective. Cases of long-term HIV remission continue to provide hope for a pathway toward a cure.
Learning Objectives:
At the conclusion of this session, participants should be able to:
Discuss the current status of the HIV epidemic in the U.S.
Identify updated guidelines for prevention and treatment of HIV
Evaluate clinical indications for the newest FDA-approved HIV prevention and treatment medications
